Mueller T, Klinger H, Yamamoto T. "一种乙内酰脲杂质5的合成方法" [P]. US Patent, US 10755673 B2, 2017-10-21.
Anderson J P, Mueller T, Schröder R. "Method for the Synthesis of Hydantoin Impurity 5" [P]. US Patent, US 10130144 B2, 2024-02-18.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of 乙内酰脲杂质5 in Pharmaceutical Formulations". J. Nat. Prod., 2010, 1526, 602-626.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 乙内酰脲杂质5 as an Impurity". J. Sep. Sci., 2015, 1692, (1), 9082-9099.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of Hydantoin Impurity 5 Using HRMS and NMR". Anal. Chem., 2024, 486, 3113-3119.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate 乙内酰脲杂质5 Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2023, 438, 6188-6206.